SerratioPlus™ is exclusively available in some international markets through trusted distributors who partner with Enzyme Science to make this and other products available to their consumers. Customers located in China may purchase this product from here.
Unfortunately, this product has been discontinued in the United States by Enzyme Science. We are tremendously grateful to our many practitioners and consumers who have enjoyed the extraordinary quality offered by this formula, and we encourage these US customers to try MyoMend™, a similar proteolytic enzyme product. This discontinuation was a voluntary one by Enzyme Science to provide focus to our product portfolio. This item has never been recalled or subject to any FDA warning letters or other guidance documents.
We stand behind our quality, and any concerned customers are encouraged to contact us with any questions.
Serratiopeptidase's profound achievements are now being recognized worldwide. The numerous benefits this enzyme has demonstrated in laboratory settings include powerful fibrinolytic and caseinolytic properties.
This unique enzyme was initially discovered in the digestive tract of the Japanese silkworm where Serratia bacteria produce it. Since its discovery, the enzyme industry has perfected growing the in industrial settings to produce sufficient quantities for use therapeutically. Clinicians and researchers in Japan and Europe have taken advantage of these Serratiopeptidase sources for the past 40 years.